The Atrial Fibrillation Ablation Pilot Study: an European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association
D. Wood(University Hospital of Heraklion), Josép Brugada(Universitat de Barcelona), Gerhard Hindricks, Luigi Tavazzi(Cornell University), Georges H. Mairesse(Cliniques du Sud Luxembourg), Malika Manini(European Society of Cardiology), Frédéric Anselme(Université de Rouen Normandie), Serge A. Trines(Leiden University), George Theodorakis(Henry Dunant Hospital), Pierre Jaı̈s(Montreal Heart Institute), Julián Pérez‐Villacastín(Hospital Clínico San Carlos), Sam Riahi(Aalborg University), Josef Kautzner(Institute of Clinical and Experimental Medicine), Thorsten Lewalter(München Klinik), Zbigniew Kalarus, Giuseppe Inama(Azienda Ospedaliera Ospedale Maggiore), Panos Vardas(Walsh University), Miloš Táborský(University of Belgrade), Aldo P. Maggioni, Roberto Ferrari(Arcispedale Sant'Anna), Michel Komajda(Institute of Cardiology), John M. Morgan(Maria Cecilia Hospital), Cécile Laroche(European Society of Cardiology), Gérard Gracia, Ángeles Alonso, Gerhard Hindriks(European Society of Cardiology)
Cited by 211
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2013|3.4k
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|Heart Rhythm|2017|2.7k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
|New England Journal of Medicine|2003|2.5k